Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pow-Sang

Showing results (231-240 of 264) with videos related to

Pageof 27
Sort By:
Journal of Clinical Trials|February 18, 2014
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome MeasuresNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Neuro-Oncology|October 7, 2025
Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trialRupesh Kotecha, Omer Gal, Haley Appel, et al.
Contemporary Clinical Trials|November 22, 2011
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancerNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.
Molecular Urology|January 16, 2002
Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional studyA Tewari, M Issa, R El-Galley, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 16, 2015
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer PreventionNagi B Kumar, Julio Pow-Sang, Kathleen M Egan, et al.
Journal of Oncology Practice|January 1, 2015
If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical recordsGwendolyn P Quinn, Rebecca G Block, Marla L Clayman, et al.
PLOS Global Public Health|March 24, 2023
Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021Shilpa Hakre, Evelyn Y Lam, Irina Maljkovic-Berry, et al.
European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Pageof 27

Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
Journal of Clinical Trials|February 18, 2014
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome MeasuresNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Neuro-Oncology|October 7, 2025
Radiation therapy (RT) alone versus RT plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trialRupesh Kotecha, Omer Gal, Haley Appel, et al.
Contemporary Clinical Trials|November 22, 2011
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancerNagi Kumar, Theresa Crocker, Tiffany Smith, et al.
Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.
Molecular Urology|January 16, 2002
Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional studyA Tewari, M Issa, R El-Galley, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 16, 2015
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer PreventionNagi B Kumar, Julio Pow-Sang, Kathleen M Egan, et al.
Journal of Oncology Practice|January 1, 2015
If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical recordsGwendolyn P Quinn, Rebecca G Block, Marla L Clayman, et al.
PLOS Global Public Health|March 24, 2023
Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021Shilpa Hakre, Evelyn Y Lam, Irina Maljkovic-Berry, et al.
European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Pageof 27